Clinical Trials

107 enrolled 17 charts

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT02369458 2025-11-18

Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies

48 enrolled 12 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT00183885 2025-10-30

A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma

76 enrolled 10 charts

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03092518 2025-02-19

Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology

27 enrolled 13 charts

Adenocarcinoma, Stomach Neoplasms

NCT01905150 2024-12-11

Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer

34 enrolled 10 charts

Pancreatic Neoplasms

NCT03658304 2024-11-05

Trial of Mitomycin C During Nephroureterectomy for Urothelial Carcinoma

29 enrolled 11 charts

Phase 3 Active not recruiting

Carcinoma, Transitional Cell

NCT05243550 2024-11-04

ENVISION

240 enrolled 20 charts 1 FDA

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT02040142 2024-10-24

HIPEC for Peritoneal Carcinomatosis

GastrointestinalGynecologic

51 enrolled 12 charts

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Stomach Neoplasms, Colorectal Neoplasms

NCT00981656 2024-09-19

Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer

37 enrolled 19 charts

Urinary Bladder Neoplasms

NCT02891447 2024-09-19

Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer

Phase 2 Active not recruiting

24 enrolled 10 charts

Gynecologic

Peritoneal Neoplasms

NCT03018418 2024-09-19

Proton Therapy in Reducing Toxicity in Anal Cancer

14 enrolled 14 charts

Anus Neoplasms

NCT05136898 2024-09-19

Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)

8 enrolled 18 charts

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT04688931 2024-06-06

ATLAS

Phase 3 Terminated

282 enrolled 29 charts

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT01004978 2024-01-03

Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

235 enrolled 12 charts

Carcinoma, Hepatocellular

NCT00003907 2023-07-05

Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver

50 enrolled 8 charts

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Metastasis

NCT02695771 2023-04-21

BIC

101 enrolled 11 charts

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT03617913 2023-01-06

Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer

2 enrolled 8 charts

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

NCT02316171 2022-07-27

CANON

Phase 1 Completed

16 enrolled 8 charts

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT01324141 2021-11-23

Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer

Phase 1 Terminated

6 enrolled 28 charts

Anus Neoplasms, Dermatitis

NCT00318643 2021-10-29

Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer

Phase 1/2 Completed

27 enrolled 14 charts

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT02092298 2021-06-15

Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric Cancer

21 enrolled 7 charts

Gastrointestinal Neoplasms

NCT02793128 2020-12-22

Olympus

71 enrolled 16 charts 2 FDA

Carcinoma, Carcinoma, Transitional Cell

NCT00296322 2020-01-18

Trial of Adjuvant Chemotherapy for Gastric Cancer

528 enrolled 8 charts

Stomach Neoplasms

NCT00276744 2018-10-24

Individualized Drug Treatment for Treating Patients With Pancreatic Cancer

Phase 2 Terminated

249 enrolled 4 charts

Pancreatic Neoplasms

NCT01580410 2018-07-03

Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix

136 enrolled 14 charts

Appendiceal Neoplasms

NCT01296763 2016-03-22

Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer

Phase 1 Completed

18 enrolled 12 charts

Pancreatic Neoplasms

NCT00271011 2015-12-03

A Study of Mitomycin C, Irinotecan, and Cetuximab

Phase 2 Terminated

13 enrolled 5 charts

Colorectal Neoplasms

NCT00974818 2015-11-20

Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients

Phase 3 Terminated

50 enrolled 7 charts

Phase EARLY_PHASE1 Completed

Urinary Bladder Neoplasms

NCT00734994 2015-06-29

Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer

15 enrolled 5 charts

Non-Muscle Invasive Bladder Neoplasms

NCT00296335 2014-02-27

Trial of Adjuvant Chemotherapy for Gastric Cancer

855 enrolled 10 charts